154 related articles for article (PubMed ID: 7321322)
1. [Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase (PAP) in blood by PAP RIA kit "EIKEN" (author's transl)].
Kida T; Higuchi Y
Kaku Igaku; 1981 Aug; 18(7):907-15. PubMed ID: 7321322
[No Abstract] [Full Text] [Related]
2. Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase in serum with Eiken PAP RIA kit.
Kida T; Higuchi Y
Oncology; 1983; 40(5):346-50. PubMed ID: 6621997
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the measurement of serum prostatic acid phosphatase with RIA-Quant PAP test kit (author's transl)].
Kawamura J; Yoshida O; Kousaka T; Yoshii M; Morita R; Torizuka K
Kaku Igaku; 1982 Mar; 19(2):313-22. PubMed ID: 7109329
[No Abstract] [Full Text] [Related]
4. [Fundamental and clinical study of PAP 'Eiken' (author's transl)].
Higuchi Y; Kida T
Kaku Igaku; 1981 Dec; 18(10):1451-7. PubMed ID: 6176743
[No Abstract] [Full Text] [Related]
5. [Evaluation of a double antibody radioimmunoassay kit for prostatic acid phosphatase (PAP) (author's transl)].
Yoshii M; Kousaka T; Morita R; Torizuka K; Kawamura J
Kaku Igaku; 1981 Dec; 18(10):1473-83. PubMed ID: 6176744
[No Abstract] [Full Text] [Related]
6. Bone scintigraphy and serum phosphatases in the detection and follow-up of bone metastases in prostatic cancer.
Liewendahl K; Alfthan O; Ikonen T; Ruutu M; Rannikko S
Scand J Urol Nephrol; 1984; 18(3):181-5. PubMed ID: 6494827
[TBL] [Abstract][Full Text] [Related]
7. [Radioimmunoassay of prostatic acid phosphatase in serum used "PAP Eiken" kit].
Hashimoto N; Maruoka Y; Harada M
Horumon To Rinsho; 1982 Aug; 30(8):869-72. PubMed ID: 7139985
[No Abstract] [Full Text] [Related]
8. Prognostic value of raised prostatic acid phosphatase and negative skeletal scintigraphy in prostatic cancer.
Goodman CM; Cumming JA; Ritchie AW; Chisholm GD
Br J Urol; 1991 Jun; 67(6):622-5. PubMed ID: 2070208
[TBL] [Abstract][Full Text] [Related]
9. [Bone scintigraphy, plasma ALP, TAP and PAP in patients with prostatic cancer].
Imamura A; Hoshi H; Jinnouchi S; Samejima M; Watanabe K
Kaku Igaku; 1988 Feb; 25(2):177-81. PubMed ID: 3386031
[No Abstract] [Full Text] [Related]
10. [A radioimmunoassay kit for measurement of human prostatic acid phosphatase (author's transl)].
Imazeki K; Kawana M; Arimizu N; Uchiyama G; Maruoka M; Shimazaki J
Kaku Igaku; 1981 Jul; 18(6):869-75. PubMed ID: 7311136
[No Abstract] [Full Text] [Related]
11. [Basic and clinical studies of radioimmunoassay kit for prostatic acid phosphatase (author's transl)].
Maruoka M; Suzuki S; Sato K; Nozumi K; Yasuda K; Ito H; Shimazaki J
Kaku Igaku; 1981 Dec; 18(10):1523-9. PubMed ID: 7341812
[No Abstract] [Full Text] [Related]
12. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
[TBL] [Abstract][Full Text] [Related]
13. Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer.
Hetherington JW; Siddall JK; Cooper EH
Eur Urol; 1988; 14(1):1-5. PubMed ID: 2449352
[TBL] [Abstract][Full Text] [Related]
14. [The value of PAP RIA in screening prostatic cancer and in detecting therapeutic effects (author's transl)].
Miki M; Machida T; Ohishi Y; Kido A; Yanagisawa M; Yoshida M; Higashi Y; Morikawa J
Kaku Igaku; 1981 Aug; 18(7):941-6. PubMed ID: 7321325
[No Abstract] [Full Text] [Related]
15. [Measurement of serum prostatic acid phosphatase by radioimmunoassay--evaluation of "GammaDab PAP kit" (author's transl)].
Hibi N; Yamazaki H; Tsukada Y; Hirai H
Kaku Igaku; 1982 Feb; 19(1):105-14. PubMed ID: 7077873
[No Abstract] [Full Text] [Related]
16. [Relation between serum PAP (prostate acid phosphatase) and bone scintigraphy in prostatic cancer].
Aizawa T; Itoh T; Tsujino S; Namiki K; Miki M
Kaku Igaku; 1992 Nov; 29(11):1277-83. PubMed ID: 1484418
[TBL] [Abstract][Full Text] [Related]
17. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
Gaca A; Panitz N
Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate.
Merrick MV; Ding CL; Chisholm GD; Elton RA
Br J Urol; 1985 Dec; 57(6):715-20. PubMed ID: 4084732
[TBL] [Abstract][Full Text] [Related]
19. [Phosphatases and bone scan in prostatic cancer].
Urrutia M; Montero J; Grade J; Llopis M
Actas Urol Esp; 1977; 1(4):207-12. PubMed ID: 567001
[No Abstract] [Full Text] [Related]
20. [Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer (II): Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and tumor markers in blood and urine].
Nemoto S; Rinsho K
Nihon Hinyokika Gakkai Zasshi; 1984 Jan; 75(1):53-8. PubMed ID: 6539837
[No Abstract] [Full Text] [Related]
[Next] [New Search]
